Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06396481
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:34.339833+00:00
Published At
2024-05-02T00:00:00+00:00
Record Updated At
2024-05-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["GBM", "DIPG Brain Tumor", "Medulloblastoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-05-02"
protocolSection.identificationModule.nctId
"NCT06396481"
protocolSection.identificationModule.officialTitle
"Clinical Study of Allogeneic V\u03b39V\u03b42 T Cells in the Treatment of Brain Malignant Glioma"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • GBM (protocolSection.conditionsModule.conditions)
  • DIPG Brain Tumor (protocolSection.conditionsModule.conditions)
  • Medulloblastoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.